Well it’s an unusual situation.
Your statement about the obvious effectiveness is a little premature.
As for the trials. There will be many people aware of the accuracy of the technology during the trial: especially all the doctors involved. While they only have anecdotal observations and not overall sensitivity and specificity they will have a view and could buy or sell accordingly
Well it’s an unusual situation. Your statement about the obvious...
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.85 |
Change
-0.080(4.15%) |
Mkt cap ! $158.2M | |||
| Open | High | Low | Value | Volume |
| $1.92 | $1.92 | $1.85 | $76.06K | 40.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 788 | $1.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.88 | 26923 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| EMV (ASX) Chart |